ClinicalTrials.Veeva

Menu

Registration Study of Amyotrophic Lateral Sclerosis (ALS) in Mainland China (ChALSR)

P

Peking University

Status

Unknown

Conditions

Amyotrophic Lateral Sclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT04328675
FDongsheng-81873784

Details and patient eligibility

About

A multi-center registration study of natural history and clinical characteristics of ALS in mainland China

Full description

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease of unknown etiology that is currently incurable. This study is a national multi-center registration study. The study collects general information of ALS patients including medical history, disease characteristics, clinical treatment data, and patient information for different visits in different centers. The aim of the study is: a) describe the distribution of ALS in mainland China(explore the differences in the number of ALS at different times, different regions, and different populations) and further find the reasons that affect the distribution of ALS, b) study the development of ALS in mainland China and the corresponding changes in the characteristics of the disease, c) explore factors that influence the prognosis of ALS.

Enrollment

4,752 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of laboratory-supported probable, probable, or definite ALS according to EI Escorial diagnostic criteria
  • Age: 18-70 years

Exclusion criteria

  • Refuse to cooperate or reject the informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Dongsheng Fan, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems